A Patient’s Guide to Taking Coumadin/Warfarin
2009; Lippincott Williams & Wilkins; Volume: 119; Issue: 8 Linguagem: Inglês
10.1161/circulationaha.108.803957
ISSN1524-4539
AutoresKaren Fiumara, Samuel Z. Goldhaber,
Tópico(s)Pharmacogenetics and Drug Metabolism
ResumoHomeCirculationVol. 119, No. 8A Patient's Guide to Taking Coumadin/Warfarin Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBA Patient's Guide to Taking Coumadin/Warfarin Karen Fiumara, PharmD and Samuel Z. Goldhaber, MD Karen FiumaraKaren Fiumara From the Pharmacy Department and Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. and Samuel Z. GoldhaberSamuel Z. Goldhaber From the Pharmacy Department and Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Originally published3 Mar 2009https://doi.org/10.1161/CIRCULATIONAHA.108.803957Circulation. 2009;119:e220–e222Warfarin (brand names Coumadin and Jantoven) is a prescription medication used to prevent harmful blood clots from forming or growing larger. Beneficial blood clots prevent or stop bleeding, but harmful blood clots can cause a stroke, heart attack, deep vein thrombosis, or pulmonary embolism. Because warfarin interferes with the formation of blood clots, it is called an anticoagulant. Many people refer to anticoagulants as "blood thinners"; however, warfarin does not thin the blood but instead causes the blood to take longer to form a clot.How Does Warfarin Work?The formation of a clot in the body is a complex process that involves multiple substances called clotting factors. Warfarin decreases the body's ability to form blood clots by blocking the formation of vitamin K–dependent clotting factors. Vitamin K is needed to make clotting factors and prevent bleeding. Therefore, by giving a medication that blocks the clotting factors, your body can stop harmful clots from forming and prevent clots from getting larger.Monitoring and Dosing TipsThe goal of warfarin therapy is to decrease the clotting tendency of blood, not to prevent clotting completely.Therefore, the effect of warfarin must be monitored carefully with blood testing. On the basis of the results of the blood test, your daily dose of warfarin will be adjusted to keep your clotting time within a target range.The blood test used to measure the time it takes for blood to clot is referred to as a prothrombin time test, or protime (PT). The PT is reported as the International Normalized Ratio (INR). The INR is a standardized way of expressing the PT value. The INR ensures that PT results obtained by different laboratories can be compared. It is important to monitor the INR (at least once a month and sometimes as often as twice weekly) to make sure that the level of warfarin remains in the effective range. If the INR is too low, blood clots will not be prevented, but if the INR is too high, there is an increased risk of bleeding. This is why those who take warfarin must have their blood tested so frequently.Unlike most medications that are administered as a fixed dose, warfarin dosing is adjusted according to the INR blood test results; therefore, the dose usually changes over time. Coumadin/warfarin pills come in different colors, and each color corresponds to a different dose (Figure). Download figureDownload PowerPointFigure. Appearance of brand-name Coumadin vs generic warfarin pills.Difference Between Brand-Name and Generic MedicationsGeneric drugs are supposed to have the same dosage, therapeutic effects, route of administration, side effects, and strength as the original drug. The US Food and Drug Administration requires that all generic drugs be as safe and effective as brand-name drugs. Generic drugs are often less expensive than their brand-name counterparts, because the generic manufacturers have not incurred the expenses of developing and marketing a new drug. In the United States, trademark laws do not allow generic drugs to look exactly like the brand-name drug; however, the generic drug must have the same active ingredients. In the case of Coumadin (a brand-name product) and warfarin (a generic product), the manufacturers attempted to keep the colors consistent with the strength of the pills. The goal is to allow the patient to identify the color-coded dose and prevent mix-ups or errors. Therefore, if the color or dose of the dispensed tablet appears different from the pill taken previously, the patient should immediately notify the dispensing pharmacist or healthcare provider.In January 2006, the Food and Drug Administration issued a public health advisory to healthcare professionals and consumers that US prescriptions filled abroad may give patients the wrong active ingredient for treating their health condition. Some Food and Drug Administration–approved products have the same brand names as drug products that are marketed outside the United States but contain completely different active ingredients. Therefore, patients who fill US prescriptions abroad, either when traveling or when shopping at foreign Internet pharmacies, need to maintain caution and vigilance. We advise US residents against purchasing drugs at foreign Internet pharmacies. Foreign drugs may use identical or potentially confusing brand names for products with active ingredients that differ from US drugs. Warfarin has many foreign brand names (Table 1). Patients who do fill prescriptions abroad should ensure the accuracy and quality of the medication dispensed. Table 1. Foreign Brand Names for WarfarinCountryForeign Brand Name for WarfarinAustraliaWarfarin, MarevanCanadaApo-WarfarinIndonesiaSimarc-2PortugalVarfineSpainAldocumarThailandBefarin, Maforan, FargemTurkeyOrfarinVenezuelaAnasmol, CumarWarfarin must be taken exactly as prescribed. Never increase or decrease your dose unless instructed to do so by your healthcare provider. If a dose is missed or forgotten, call your healthcare provider for advice.Side EffectsThe major complications associated with warfarin are clotting due to underdosing or bleeding due to excessive anticoagulation. The most serious bleeding is gastrointestinal or intracerebral. Excessive bleeding can occur in any area of the body, and patients taking warfarin should report any falls or accidents, as well as signs or symptoms of bleeding or unusual bruising, to their healthcare provider. Signs of unusual bleeding include bleeding from the gums, blood in the urine, bloody or dark stool, a nosebleed, or vomiting blood. An unusual headache or a headache that is more severe than usual may signal intracerebral bleeding.When to Call Your Healthcare ProviderIf you experience the following signs of bleeding, you should call 911 or your healthcare provider immediately: Severe headache, confusion, weakness, or numbnessCoughing up large amounts of bright red bloodVomiting bloodBleeding that will not stopBright red blood in stoolFall or injury to the headHeadache that is severe or unusualSome simple changes to decrease the risk of bleeding while taking warfarin include the following: Use a soft-bristle toothbrushFloss with waxed floss rather than unwaxed flossShave with an electric razor rather than a bladeTake care when using sharp objects, such as knives and scissorsAvoid activities that have a risk of falling or injury (eg, contact sports)Warfarin and LifestyleChanges in daily living can affect the INR. It is important to know common do's and don'ts for warfarin therapy (Table 2). Table 2. Common Do's and Don'tsWhat to DoWhat Not to DoDo watch for signs and symptoms of bleeding.Never double a dose because you missed a dose.Do tell your healthcare provider when you get sick or hurt.Don't start new medications, herbals, or supplements without talking to your healthcare provider.Do take warfarin exactly as prescribed.Don't make changes to your warfarin dose without talking to your healthcare provider.Do tell anyone giving you medical or dental care that you are taking warfarin.Do keep appointments for blood tests.PregnancyWarfarin is not recommended during pregnancy. A woman who becomes pregnant or plans to become pregnant while undergoing warfarin therapy should notify her healthcare provider immediately.Surgery/Dental and Other Medical ProceduresIt is important to tell all your healthcare providers that you are taking warfarin. If you are having surgery, dental work, or other medical procedures, you may need to stop taking warfarin.TravelCheck with your healthcare provider if you expect to travel. While traveling, it is important to carry your medication with you at all times. Do not put medication into checked baggage.Warfarin Interacts With Other MedicationsPatients who take warfarin should consult with their healthcare provider before taking any new medication, including over-the-counter (nonprescription) drugs, herbal medicines, vitamins, or any other products. Many medications can alter the effectiveness of warfarin, resulting in an INR that is either too high or too low. Some of the most common over-the-counter pain relievers, such as ibuprofen (brand name Advil) and naproxen (brand name Aleve), enhance the anticoagulant effects of warfarin and increase the likelihood of harmful bleeding.Warfarin Interacts With Alcohol and With Certain FoodsAlcoholAlcohol intake can affect how the body metabolizes warfarin. Patients undergoing warfarin therapy should avoid drinking alcohol on a daily basis. Alcohol should be limited to no more than 1 to 2 servings of alcohol occasionally. The antiplatelet effect of alcohol increases the risk of major bleeding, even if the INR remains within the target range.FoodsSome foods can interfere with the effectiveness of warfarin. The most important point to remember is to eat what you normally eat and not to make any major changes in your diet without contacting your healthcare provider.Vitamin KEating an increased amount of foods rich in vitamin K can lower the PT and INR, making warfarin less effective and potentially increasing the risk of blood clots. Patients who take warfarin should aim to eat a relatively similar amount of vitamin K each week. The highest amount of vitamin K is found in green and leafy vegetables such as broccoli, lettuce, and spinach. It is not necessary to avoid these foods; however, it is important to try to keep the amount of vitamin K you eat consistent.Wear Medical IdentificationThose who require long-term warfarin should wear a medical alert bracelet, necklace, or similar alert tag at all times. If an accident occurs and the person is too ill to communicate, a medical alert tag will help responders provide appropriate care. The alert should include a list of major medical conditions and the reason warfarin is needed, as well as the name and phone number of an emergency contact.Where to Get More InformationYour healthcare provider is the best source of information for questions and concerns related to your medical problem. Because no 2 patients are exactly alike, and recommendations can vary from 1 person to another, it is important to seek guidance from a provider who is familiar with your individual condition.A number of World Wide Web sites have information about medical problems and treatments, although it can be difficult to know which sites are reputable. The National Institutes of Health and the North American Thrombosis Forum Information provide reliable information.The information contained in this Circulation Cardiology Patient Page is not a substitute for medical advice, and the American Heart Association recommends consultation with your doctor or healthcare professional.DisclosuresDr Goldhaber receives research support from and consults for Bristol-Myers Squibb. Dr Fiumara reports no conflicts.FootnotesCorrespondence to Samuel Z. Goldhaber, MD, 75 Francis St, Boston, MA 02115. E-mail [email protected]Additional Resources1 US National Library of Medicine. Medline Plus: health topics. Available at: http://www.nlm.nih.gov/medlineplus/healthtopics.html.Google Scholar2 North American Thrombosis Forum. Available at: http://www.natfonline.org.Google Scholar3 Venous Disease Coalition. Available at: http://venousdiseasecoalition.org.Google Scholar4 ClotCare. ClotCare online resource. Avaiable at: http://www.clotcare.com.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Matsumoto C (2018) Alcohol Encyclopedia of Cardiovascular Research and Medicine, 10.1016/B978-0-12-809657-4.99607-8, (49-57), . Matsumoto C (2018) OBSOLETE: Alcohol Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99607-7, . Kuljis J, Money A, Perry M, Barnett J and Young T (2016) Technology-assisted self-testing and management of oral anticoagulation therapy: a qualitative patient-focused study, Scandinavian Journal of Caring Sciences, 10.1111/scs.12374, 31:3, (603-617), Online publication date: 1-Sep-2017. Lane D, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan G, Hills M, Hylek E, LaHaye S, Lip G, Lobban T, Mandrola J, McCabe P, Pedersen S, Pisters R, Stewart S, Wood K, Potpara T, Gorenek B, Conti J, Keegan R, Power S, Hendriks J, Ritter P, Calkins H, Violi F and Hurwitz J (2015) Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), Europace, 10.1093/europace/euv233, 17:12, (1747-1769), Online publication date: 1-Dec-2015. Hasan S, Teh K, Ahmed S, Chong D, Ong H and Naina B (2015) Quality of life (QoL) and International Normalized Ratio (INR) control of patients attending anticoagulation clinics, Public Health, 10.1016/j.puhe.2015.05.014, 129:7, (954-962), Online publication date: 1-Jul-2015. Roth J, Bradley K, Thummel K, Veenstra D and Boudreau D (2015) Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting, Pharmacoepidemiology and Drug Safety, 10.1002/pds.3769, 24:6, (619-627), Online publication date: 1-Jun-2015. (2014) Good Clinical Practice Handbook of Bioequivalence Testing, 10.1201/b17582-28, (756-787) Matsumoto C, Miedema M, Ofman P, Gaziano J and Sesso H (2014) An Expanding Knowledge of the Mechanisms and Effects of Alcohol Consumption on Cardiovascular Disease, Journal of Cardiopulmonary Rehabilitation and Prevention, 10.1097/HCR.0000000000000042, 34:3, (159-171), Online publication date: 1-May-2014. Giglia T, Massicotte M, Tweddell J, Barst R, Bauman M, Erickson C, Feltes T, Foster E, Hinoki K, Ichord R, Kreutzer J, McCrindle B, Newburger J, Tabbutt S, Todd J and Webb C (2013) Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease, Circulation, 128:24, (2622-2703), Online publication date: 17-Dec-2013. Dewhurst C, Kane R, Mhuircheartaigh J, Brook O, Sun M and Siewert B (2012) Complication Rate of Ultrasound-Guided Percutaneous Cholecystostomy in Patients With Coagulopathy, American Journal of Roentgenology, 10.2214/AJR.11.8445, 199:6, (W753-W760), Online publication date: 1-Dec-2012. March 3, 2009Vol 119, Issue 8 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.108.803957PMID: 19255348 Originally publishedMarch 3, 2009 PDF download Advertisement SubjectsAnticoagulantsPharmacologyThrombosisTreatment
Referência(s)